10-K: Acadia Healthcare Reports Increased Bed Count and Revenue Growth in 2024 Annual Filing

Acadia Healthcare's 2024 10-K filing reveals growth in bed count and revenue, alongside ongoing legal and regulatory challenges.

Summary

• Acadia Healthcare operated 262 behavioral healthcare facilities with approximately 11,850 beds in 39 states and Puerto Rico as of December 31, 2024.
• The company added 776 beds during 2024, including 312 to existing facilities and 464 through new facilities and joint ventures.
• Nine comprehensive treatment centers (CTCs) were opened during the year.
• Revenue for 2024 reached $3,154.0 million, compared to $2,928.7 million in 2023.
• The company acquired Turning Point Centers, a 76-bed specialty provider, in February 2024.
• Acadia borrowed $305.0 million on its Revolving Facility and repaid $15.0 million during 2024.
• The company is facing ongoing governmental investigations and legal proceedings, including securities litigation and derivative actions.
• A share repurchase program was authorized by the board of directors on February 25, 2025, allowing for the acquisition of up to $300.0 million of outstanding shares.
• The company is working to replace the Revolving Facility and the Term Loan Facility with a new $1.0 billion, five-year senior secured revolving credit facility and a new $650 million, five-year senior secured term loan.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there's revenue growth and expansion, significant legal expenses and ongoing investigations temper the positive aspects.

Positives

• Acadia Healthcare's revenue increased by 7.7% to $3,154.0 million in 2024.
• The company added 776 beds and opened nine CTCs during the year.
• Acadia acquired Turning Point Centers in February 2024.
• A share repurchase program was authorized by the board of directors on February 25, 2025, allowing for the acquisition of up to $300.0 million of outstanding shares.
• The company is working to replace the Revolving Facility and the Term Loan Facility with a new $1.0 billion, five-year senior secured revolving credit facility and a new $650 million, five-year senior secured term loan.

Negatives

• The company is facing ongoing governmental investigations and legal proceedings, including securities litigation and derivative actions.
• Legal settlements expense for the year ended December 31, 2023 was $394.2 million associated with the Desert Hills Litigation.
• The company recorded non-cash impairment charges totaling $17.3 million related to the closure of certain facilities.

Risks

• The company is subject to governmental investigations, regulatory actions, whistleblower lawsuits and other legal proceedings.
• Failure to comply with extensive laws and government regulations could result in penalties or significant changes to operations.
• Debt could adversely affect financial health and prevent fulfilling obligations under financing arrangements.
• An incident involving one or more patients or the failure to provide appropriate care could result in increased regulatory burdens, governmental investigations, litigation, negative publicity and adversely affect the trading price of the common stock.
• A cybersecurity incident could have a material adverse impact on the company, including substantial sanctions, fines, and damages and civil and criminal penalties under federal and state privacy laws, in addition to reputational harm and increased costs.
• The company faces competition for staffing, labor shortages and higher turnover rates that may increase labor costs and reduce profitability.

Future Outlook

Management expects to take advantage of several strategies that are more accessible as a result of increased size and geographic scale, including continuing a national marketing strategy to attract new patients and referral sources, increasing volume of out-of-state referrals, providing a broader range of services to new and existing patients and clients and selectively pursuing opportunities to expand facility and bed count through acquisitions, wholly-owned de novo facilities, joint ventures and bed additions in existing facilities.

Industry Context

The behavioral healthcare industry is highly fragmented and undergoing consolidation to better serve the growing need for acute behavioral healthcare services.

Comparison to Industry Standards

• The document mentions Universal Health Services, Inc. (NYSE: UHS) as a principal competitor.
• Acadia is positioned as a leading platform in a highly fragmented industry.
• The company competes with other acute inpatient psychiatric hospitals, residential behavioral healthcare providers, and general healthcare facilities that provide mental health services.

Legal Proceedings

• The company is involved in multiple legal proceedings, including securities litigation, derivative actions, and government investigations.
• On July 7, 2023, in connection with one of the lawsuits in our Desert Hills Litigation, a jury awarded the plaintiff compensatory damages of $80.0 million and punitive damages of $405.0 million.
• On October 30, 2023, the Company and Desert Hills entered into settlement agreements in connection with the Inman Litigation, as well as two other related cases.
• On January 19, 2024, pursuant to the terms of the settlement agreements, the Company paid an aggregate amount of $400.0 million in exchange for the release and discharge of all claims arising from, relating to, concerning or with respect to all harm, injuries or damages asserted in such cases or that may be asserted in the future by the plaintiffs in those cases.
• On September 23, 2024, the Company entered into a civil settlement agreement with the federal government (the 2017 OIG/DOJ Settlement Agreement), which fully resolved the 2017 OIG/DOJ Investigation with no admission of liability or wrongdoing by the Company.
• During the year ended December 31 2024, pursuant to the 2017 OIG/DOJ Settlement Agreement, the Company paid $19.9 million, plus interest, to the federal government and four states that participated in the 2017 OIG/DOJ Investigation in exchange for the release and discharge of any civil or administrative monetary claims arising from the 2017 OIG/DOJ Investigation.
• In September 2024, the Company received a grand jury subpoena from the United States District Court for the Western District of Missouri (the W.D.Mo.), issued by attorneys from the Criminal Division of the U.S. Department of Justice (the DOJ Criminal Division), related to the Companys acute care service line and related admissions, length of stay and billing practices.
• The Company has also received subpoenas from the United States Securities and Exchange Commission (the SEC) requesting similar information as well as information relating to the CTC service line.

Stakeholder Impact

• The company's performance impacts shareholders, employees, patients, and communities it serves.
• Legal proceedings and regulatory actions could affect the company's reputation and ability to provide services.
• The company is committed to providing high-quality, cost-effective behavioral healthcare services to the communities it serves.

Next Steps

• The company is working to replace the Revolving Facility and the Term Loan Facility with a new $1.0 billion, five-year senior secured revolving credit facility and a new $650 million, five-year senior secured term loan.
• The company intends to cooperate with any requests for information from members of the United States Congress related to, among other things, the Companys admissions, length of stay, billing practices, and opioid treatment programs.

Key Dates

Keywords

behavioral healthcare, revenue growth, acquisitions, legal proceedings, bed count, CTC, debt, regulation, risk factors